Artificial Intelligence + Care Coach Intervention

NCT05352399 | Completed Results

• 1 other identifier: 2000032226
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this research study is to develop and test an artificial intelligence intervention for emergency department (ED) discharge care transitions experienced by caregivers of older adults with cognitive impairment.

Conditions

Dementia; Caregiver; Emergency Department; Artificial Intelligence; Care Transition

Outcome Measures

Primary Outcomes (4)

• Intervention Appropriateness Measure

  Appropriateness is defined as the perceived fit, relevance, or compatibility of the innovation for a given setting or consumer, and/or perceived fit of the innovation to address a particular issue or problem. The measure consists of 4 questions, with an overall score range of 4-20 (higher scores suggest increased appropriateness). Administration time is 1-2 minutes. Measured by survey.

  Day 7 and 30

• Feasibility of Intervention Measure

  Feasibility is defined as the extent to which a new innovation can be successfully used or carried out within a given setting. The measure consists of 4 questions, with an overall score range of 4-20 (higher scores suggest increased feasibility). Administration time is 1-2 minutes. Measured by survey.

  Day 7 and 30

• Acceptability of Intervention Measure

  Acceptability is defined as the perception that a given innovation is agreeable, palatable, or satisfactory. The measure consists of 4 questions, with an overall score range of 4-20 (higher scores suggest increased acceptability). Administration time is 1-2 minutes. Measured by survey.

  Day 7 and 30

• System Usability Scale

  Usability encapsulates several aspects including subjective component assessments of effectiveness, efficiency, and satisfaction. The System Usability Scale consists of 10 questions on effectiveness, efficiency, and satisfaction, with an overall score range of 10-50 (higher scores suggest increased usability). Administration time is 3-5 minutes. Measured by survey.

  Day 7 and 30

Secondary Outcomes (4)

• Quality of Life (QOL) in Alzheimer's Disease (AD) Scale (QOL-AD)

  Day 0, 7 and 30

• Dyadic Relationship Scale (DRS)

  Day 0, 7 and 30

• Zarit Caregiver Burden Scale

  Day 0, 7 and 30

• Fortinsky Caregiver Self-Efficacy Scale

  Day 0, 7, and 30

Study Arms (1)

Intervention (NeuViCare AI)

EXPERIMENTAL

An anticipated 55 participants will be part of the Intervention arm participants and will engage with NeuViCare AI, including all variations of its 5 components described further below.

Other: NeuViCare application

Interventions

NeuViCare application OTHER

Intervention arm participants will engage with NeuViCare AI, including all variations of its 5 components: 1) NeuViCare Planner - enables review of ordered tests and external resources recommended by the care provider; 2) NeuViCare Task-Support Service - provides context-sensitive, personalized text-based assistance to help patients' complete care plan captured in the NeuViCare Planner; 3) NeuViCare Resource Advisor - presents trusted, unbiased advice to locate nearby resources listed within their care plan; 4) NeuViCare Advisor - educates and trains Persons Living With Dementia (PLWD) and their care partners at the moment of need; and 5) NeuViCare Community Hub - a safe virtual space which enables care partners to interact with other peer care partners to gain their experiential knowledge and emotional support.

Intervention (NeuViCare AI)

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Older Adult (65+)

You may qualify if:

• age ≥65 years with a diagnosis of dementia within the electronic health record OR new cognitive impairment identified during an ED visit
• be fluent in English or Spanish
• discharge after an ED visit
• possession of a smart device (either a phone, tablet, or computer) that has internet access to utilize and interact with NeuViCare AI services

You may not qualify if:

• \- evidence of delirium, by the 4-AT screening tool

Sponsors & Collaborators

• Yale University: lead
• National Institute on Aging (NIA): collaborator
• Emergency Medicine Foundation: collaborator

Study Sites (1)

Yale New Haven Hospital

New Haven, Connecticut, 06519, United States

Location

MeSH Terms

Conditions

Dementia; Emergencies

Condition Hierarchy (Ancestors)

Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Neurocognitive Disorders; Mental Disorders; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Results Point of Contact

• Title: Cameron Gettel
• Organization: Yale School of Medicine

cameron.gettel@yale.edu

717-228-7759

Study Officials

• Cameron Gettel

  Yale University

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 18, 2022
• First Posted: April 28, 2022
• Study Start: March 20, 2023
• Primary Completion: June 30, 2024
• Study Completion: June 30, 2024
• Last Updated: August 5, 2025
• Results First Posted: August 5, 2025

Record last verified: 2025-07

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)